EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向：肝病方向 经验分享：请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：小肠 经验分享：个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]

2023-03-31 1473ac4am82暂无昵称来自四川省

作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。

49 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向：肝病方向 经验分享：请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：小肠 经验分享：个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]

2022-09-30 ms5000001116886064

想问下接收后多久发proof

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向：肝病方向 经验分享：请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：小肠 经验分享：个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

如果文章发表了未提供ORCIDID如何添加？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向：肝病方向 经验分享：请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：小肠 经验分享：个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]

2021-12-28 MS54455111222

什么是SCI？

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向：肝病方向 经验分享：请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：小肠 经验分享：个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]

2023-08-08 ms4000001065776869 来自北京

想问问大家现在under review大概多久会给消息？

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向：肝病方向 经验分享：请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：小肠 经验分享：个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]

2022-08-04 ms5000001116886064

偏重的研究方向：肝病方向
经验分享：请问这个杂志修回会被拒稿吗

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向：肝病方向 经验分享：请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：小肠 经验分享：个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]

2022-03-05 ms4000001510803725

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：小肠
经验分享：个案很快被拒

52 0

[GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向：肝病方向 经验分享：请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：小肠 经验分享：个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]

2022-02-16 ms2000000713462597

方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。

62 0

[GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向：肝病方向 经验分享：请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：小肠 经验分享：个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]

2021-01-28 日月花

分享一下投稿链接，谢谢

122 0

[GetPortalCommentsPageByObjectIdResponse(id=2122895, encodeId=fa5f21228958a, content=作者之一在邮箱确认和勾选声明的时候有一个勾错了，是应该主动要求退回还是等编辑退呢？目前状态是已分配稿号（上传3天后）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Fri Mar 31 08:41:42 CST 2023, time=2023-03-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2091221, encodeId=40d220912210a, content=想问下接收后多久发proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Fri Sep 30 18:11:09 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151721, encodeId=426c2151e2141, content=想问问大家现在under review大概多久会给消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909f6393155, createdName=ms4000001065776869, createdTime=Tue Aug 08 06:45:41 CST 2023, time=2023-08-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向：肝病方向 经验分享：请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：小肠 经验分享：个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向：临床胶囊内镜数据文章可能是创新不强吧，3天就被拒了，无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]

2020-06-27 ms2000001231784364

官网上找不到文章投稿格式，前辈能发一下嘛？第一次投，谢谢谢谢

175 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务